Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway

Yang,Guang-Lin; Tao,Hai-Rong; Wang,Han-Wei; Sun,Yun; Zhang,Li-Di; Zhang,Chao; He,Wei; Xu,Mang-Hua; Zhao,Jiang-Min; Gao,Feng-Hou

doi:10.3892/or.2015.3748

April-2015 Volume 33 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2015 Volume 33 Issue 4

Full Size Image

Article

Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway

Authors:
- Guang-Lin Yang
- Hai-Rong Tao
- Han-Wei Wang
- Yun Sun
- Li-Di Zhang
- Chao Zhang
- Wei He
- Mang-Hua Xu
- Jiang-Min Zhao
- Feng-Hou Gao
View Affiliations / Copyright

Affiliations: Department of General Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China, Department of Orthopaedic Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China, Department of Hematology and Rheumatology, Bengbu Third People's Hospital Affiliated to Southeast University, Bengbu, Anhui 233000, P.R. China, Department of Clinical Laboratory, Dong-Nan Hospital, Shanghai 200023, P.R. China, Institute of Oncology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China, Department of Radiology, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China
Pages: 2045-2051
|
Published online on: January 23, 2015

https://doi.org/10.3892/or.2015.3748
Expand metrics +

Abstract

Gastric cancer cell are not particularly sensitive to Ara-C, a deoxycytidine analog that affects DNA synthesis. In the present study, AGS and MKN-45 gastric cancer cell lines were treated with Ara-C to determine its role in cell proliferation and apoptosis. The antiproliferative effect of Ara-C was assessed using the Cell Counting kit-8. Gelatinase zymography was utilized to detect the activity of MMP-2 and MMP-9, and an in vitro invasion assay was performed. Using RT-PCR, CD-147, MMP-2 and MPP-9 mRNA levels were assessed in AGS cells with various doses of Ara-C treatment. CD-147, MMP-2 and MMP-9 protein levels were analysed in Ara-C‑treated AGS and MKN-45 cells. AGS cells were treated with or without U-0126 or siRNA-CD147 and/or Ara-C for 24 h, and an in vitro invasion assay was performed. Although low-dose Ara-C had no obvious effect on cell proliferation, it upregulated the expression of MMP-2, MMP-9 and CD-147 and ERK activation. Low-dose Ara-C increased gastric cancer cell invasion. U-0126 and siRNA-CD-147 inhibited the induction of Ara-C in gastric cancer cell invasion. Therefore, Ara-C enhances the invasiveness of gastric cancer cells by expression of CD-147 /MMP-2 and MMP-9 via the ERK signaling pathway. The results are therefore useful in the prevention of Ara-C collateral damage associated with standard, conventional protocols of chemotherapy administration.

View Figures

View References

1	Li R, Chen WC, Pang XQ, et al: Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer. Mol Biol Rep. 39:8755–8761. 2012. View Article : Google Scholar : PubMed/NCBI
2	Pietrantonio F, De Braud F, Da Prat V, et al: A review on biomarkers for prediction of treatment outcome in gastric cancer. Anticancer Res. 33:1257–1266. 2013.PubMed/NCBI
3	Braun S, Kentenich C, Janni W, et al: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol. 18:80–86. 2000.PubMed/NCBI
4	Aogi K, Rai Y, Ito Y, et al: Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previously treated with anthracyclines: results of a phase II study in Japan. Cancer Chemother Pharmacol. 71:1427–1433. 2013. View Article : Google Scholar : PubMed/NCBI
5	Harland S, Staffurth J, Molina A, et al: Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy. Eur J Cancer. 49:3648–3657. 2013. View Article : Google Scholar : PubMed/NCBI
6	Sawai K, Goi T, Koneri K, et al: Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report). World J Surg Oncol. 11:2032013. View Article : Google Scholar : PubMed/NCBI
7	Oyamada Y, Maeshima A, Takeuchi K and Kato R: A case of lung cancer resistant to pemetrexed responding to S-1 monotherapy. Gan To Kagaku Ryoho. 40:781–784. 2013.(In Japanese). PubMed/NCBI
8	Neuzillet C, Hentic O, Rousseau B, et al: FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts. World J Gastroenterol. 18:4533–4541. 2012. View Article : Google Scholar : PubMed/NCBI
9	Galmarini CM, Mackey JR and Dumontet C: Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol. 3:415–424. 2002. View Article : Google Scholar : PubMed/NCBI
10	Löwenberg B: Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. Blood. 121:26–28. 2013. View Article : Google Scholar : PubMed/NCBI
11	Fan X, Wu W, Shi H and Han J: RNA interference targeting CD147 inhibits the invasion of human cervical squamous carcinoma cells by downregulating MMP-9. Cell Biol Int. 37:737–741. 2013. View Article : Google Scholar : PubMed/NCBI
12	Zhao S, Ma W, Zhang M, et al: High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Med Oncol. 30:3352013. View Article : Google Scholar
13	Piao S, Zhao S, Guo F, et al: Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. J Cancer Res Clin Oncol. 138:627–635. 2012. View Article : Google Scholar : PubMed/NCBI
14	Kim JY, Kim WJ, Kim H, et al: The stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis. Immune Netw. 9:90–97. 2009. View Article : Google Scholar
15	Farabegoli F, Papi A and Orlandi M: (−)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci Rep. 31:99–108. 2011. View Article : Google Scholar
16	Chow S, Patel H and Hedley DW: Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry. 46:72–78. 2001. View Article : Google Scholar : PubMed/NCBI
17	Fukazawa H, Noguchi K, Murakami Y and Uehara Y: Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway. Mol Cancer Ther. 1:303–309. 2002.PubMed/NCBI
18	Sunayama J, Matsuda K, Sato A, et al: Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells. 28:1930–1939. 2010. View Article : Google Scholar : PubMed/NCBI
19	Hao JL, Cozzi PJ, Khatri A, et al: CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Curr Cancer Drug Targets. 10:287–306. 2010. View Article : Google Scholar : PubMed/NCBI
20	Kanekura T and Chen X: CD147/basigin promotes progression of malignant melanoma and other cancers. J Dermatol Sci. 57:149–154. 2010. View Article : Google Scholar : PubMed/NCBI
21	Nabeshima K, Iwasaki H, Koga K, et al: Emmprin (basigin/ CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int. 56:359–367. 2006. View Article : Google Scholar : PubMed/NCBI
22	Boulos S, Meloni BP, Arthur PG, et al: Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis. 25:54–64. 2007. View Article : Google Scholar
23	Kim K, Kim H, Jeong K, et al: Release of overexpressed CypB activates ERK signaling through CD147 binding for hepatoma cell resistance to oxidative stress. Apoptosis. 17:784–796. 2012. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles